Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Signature of Atrial Fibrillation for Personalized Prevention
NCT06735001Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Mar 2025
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Trial in Atrial fibrillation (AFib) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Biomarkers T1 at Day 0, Biomarkers T2 at Day 1 and 1 more. Started Mar 2025; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06735001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06735001.